Skip to content
Reverie Labs logo

Reverie Labs

Reverie Labs is a YC Winter 2018 (W18) company. Based in Cambridge, MA, USA. Team of 29.

  • AI-powered Drug Discovery
  • Machine Learning
  • Biotech

About Reverie Labs

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Reverie Labs develops brain-penetrant cancer therapies using machine learning to drive small-molecule drug discovery. The company applies AI to design and optimize compounds that can cross the blood-brain barrier, targeting cancers that are difficult to treat with conventional drugs. This replaces the slower, largely manual medicinal chemistry iteration that traditional drug discovery relies on.

From the Y Combinator listing

How Reverie Labs describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Engineering next-generation, brain-penetrant cancer therapies.

Reverie Labs is engineering next-generation, brain-penetrant cancer therapies.

Facts

Industry
Healthcare / Healthcare -> Therapeutics
Location
Cambridge, MA, USA
Team size
29
Status
Inactive
Stage
Early

Founders (3)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works